TVS Motor Company, a global two‑ and three‑wheeler manufacturer, partnered with the 2nd Chances Foundation to roll out the “TVS Signs to Look Out For” campaign, which adapts common road‑sign symbols to convey breast‑cancer warning signs across Kenya.

The initiative ran throughout October, designated Breast Cancer Awareness Month, and featured short videos that explain which breast changes merit medical assessment without delay.

Breast cancer remains Kenya’s most frequently diagnosed cancer, with the International Agency for Research on Cancer’s GLOBOCAN 2024 data estimating over 7,000 new cases and more than 3,000 deaths each year.

Late diagnosis is a major obstacle; a 2025 National Cancer Institute of Kenya report indicated that 60‑70 % of cases are identified at stage three or four, citing fear, misinformation and limited diagnostic access as key barriers.

Dr Gladwell Kiarie, president of the Kenya Society of Haematology and Oncology, noted that Kenyan women often develop breast cancer at younger ages—typically between 35 and 50—compared with Western populations.

TVS Vice President Madhu Prakash Singh said the company leveraged its mobility expertise to repurpose familiar traffic signs, such as a “bump ahead” for unusual lumps and an “uneven road” for changes in breast size or shape, to make the health message hard to ignore.

Additional symbols included traffic‑light icons reminding viewers to watch for skin or nipple alterations, while the campaign also urged men to join breast‑health conversations and support loved ones seeking care.

Waithera Kabiru, founder of 2nd Chances Foundation, emphasized that linking everyday signs to health cues can spark discussions that might otherwise be avoided, encouraging prompt medical advice even for painless changes.

The World Health Organization stresses that early diagnosis followed by timely treatment improves outcomes, a principle the campaign aims to reinforce by prompting women to seek clinical assessment for any suspicious breast change.

While most breast lumps are benign, the initiative clarifies that any unusual lump—painful or not—should be evaluated, and that awareness does not replace routine screening or professional diagnosis.